These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 391257)

  • 21. Micromethod for the determination of diphenylhydantoin in plasma and cerebrospinal fluid--a comparison between a gas chromatographic and a spectrophotometric method.
    Berlin A; Agurell S; Borgå O; Lund L; Sjöqvist F
    Scand J Clin Lab Invest; 1972 May; 29(3):281-7. PubMed ID: 5037625
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding.
    Odar-Cederlöf I; Borgå O
    Eur J Clin Pharmacol; 1974; 7(1):31-7. PubMed ID: 4852619
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter: Effect of plasma protein binding on elimination of warfarin.
    Levy G; Yacobi A
    J Pharm Sci; 1974 May; 63(5):805-6. PubMed ID: 4830012
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):552-8. PubMed ID: 1277711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in drug metabolism with increasing age: 2. phenytoin clearance and protein binding.
    Hayes MJ; Langman MJ; Short AH
    Br J Clin Pharmacol; 1975 Feb; 2(1):73-9. PubMed ID: 1234490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of acute viral hepatitis on phenytoin kinetics and protein binding.
    Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1975 Jun; 17(6):685-91. PubMed ID: 1139859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 29. The comparative enzyme-inducing properties of antiepileptic drugs [proceedings].
    Perucca E; Hedges A; Makki K; Hebdige S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1979 Apr; 7(4):414P-415P. PubMed ID: 444364
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid in epilepsy: clinical and pharmacological effects.
    Mattson RH; Cramer JA; Williamson PD; Novelly RA
    Ann Neurol; 1978 Jan; 3(1):20-5. PubMed ID: 350128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum protein binding of diphenylhydantoin in man. I. Interaction with sodium valproate.
    Lecchini S; Gatti G; De Bernardi M; Caravaggi M; Frigo GM; Calzetti S; Visintini D
    Farmaco Prat; 1978 Feb; 33(2):80-2. PubMed ID: 344060
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of the anticonvulsant drug--dipropyl acetate (Epilim) in human plasma by gas chromatography.
    U-Schulz H; Toseland PA
    Ann Clin Biochem; 1977 Jul; 14(4):240-2. PubMed ID: 332044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sodium valproate on plasma protein binding of diphenylhydantoin.
    Patsalos PN; Lascelles PT
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):570-4. PubMed ID: 20483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of phenytoin clearance by valproic acid in normal subjects.
    Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
    Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
    Levy RH; Moreland TA
    Schweiz Rundsch Med Prax; 1984 Feb; 73(6):159-63. PubMed ID: 6424205
    [No Abstract]   [Full Text] [Related]  

  • 37. Valproic acid: interactions with phenytoin and phenobarbital.
    Keys PA
    Drug Intell Clin Pharm; 1982 Oct; 16(10):737-9. PubMed ID: 6814881
    [No Abstract]   [Full Text] [Related]  

  • 38. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of anticonvulsants.
    Hvidberg EF; Dam M
    Clin Pharmacokinet; 1976; 1(3):161-88. PubMed ID: 797496
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.